KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$11.72 USD
+0.21 (1.82%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $11.99 +0.27 (2.30%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Earnings News For KALV
-
KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year
-
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update
-
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
-
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
-
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
-
Analysts Estimate KalVista Pharmaceuticals, Inc. (KALV) to Report a Decline in Earnings: What to Look Out for
-
KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Misses Revenue Estimates
-
KalVista Pharmaceuticals, Inc. (KALV) Expected to Beat Earnings Estimates: Should You Buy?
-
KalVista Pharmaceuticals (KALV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
KalVista Pharmaceuticals (KALV) Q1 Earnings Preview: What to Look Out For